Table 2.
Study | All | Wilson | Wilson Bonferroni | Clopper Pearson | Clopper Pearson Bonferroni | Hotelling | Hotelling Continuity |
---|---|---|---|---|---|---|---|
Fine | Include | Include | Include | Include | |||
Regueras | Include | ||||||
Canada | Include | ||||||
Treebupachatsak | Include | Include | Include | Include | Include | Include | Include |
Atlas | Include | Include | Include | ||||
Dagnelie | Include | ||||||
Hall et al | Include | Include | Include | Include | Include | Include | Include |
Scwartz et al | Include | Include | Include | Include | Include | Include | Include |
Seppala et al | Include | Include | Include | Include | Include | Include | Include |
McIsaac | Include | ||||||
Alper et al | Include | Include | Include | Include | Include | Include | Include |
Abu-Sabaah et al | Include | ||||||
Sensitivity (95% CI) | 50.6% (42.8-58.4) | 38.4% (30.4-47.2) | 38.4% (30.4-47.2) | 38.4% (30.4-47.2) | 39.7% (31.5-48.6) | 42.4% (35.2-49.9) | 42.4% (35.2-49.9) |
Specificity (95% CI) | 78.5% (65.7-87.4) | 92.1% (83.5-96.4) | 92.1% (83.5-96.4) | 92.1% (83.5-96.4) | 89.5% (82.4-94.0) | 88.4% (79.4-93.8) | 88.4% (79.4-93.8) |